Rebastinib Uses, Dosage, Side Effects and more
Rebastinib has been used in trials studying the treatment of Chronic Myeloid Leukemia. It is an inhibitor of Tie2 tyrosine kinase receptor and an antineoplastic agent.
| Trade Name | Rebastinib |
| Generic | Rebastinib |
| Rebastinib Other Names | Rebastinib |
| Type | |
| Formula | C30H28FN7O3 |
| Weight | Average: 553.5868 Monoisotopic: 553.223766002 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
